About Benchsci
Benchsci is a company based in Toronto (Canada) founded in 2015. Benchsci has raised $157.73 million across 8 funding rounds from investors including Northleaf, Generation Investment Management and Inovia Capital. Benchsci offers products and services including ASCEND. Benchsci operates in a competitive market with competitors including Nona Biosciences, EPITOPIC, Deep Biologics, AB-Pred and NatIgGs, among others.
- Headquarter Toronto, Canada
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Scinapsis Analytics Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$157.73 M (USD)
in 8 rounds
-
Latest Funding Round
$70 M (USD), Series D
May 25, 2023
-
Investors
Northleaf
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Benchsci
Benchsci offers a comprehensive portfolio of products and services, including ASCEND.
Generative AI tool for analyzing scientific data in pharma R&D
People of Benchsci
Unlock access to complete
Unlock access to complete
Funding Insights of Benchsci
Benchsci has successfully raised a total of $157.73M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $70 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Benchsci
Benchsci has secured backing from 12 investors, including venture fund investors. Prominent investors backing the company include Northleaf, Generation Investment Management and Inovia Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on sustainable investments
|
Locked | Locked | Locked | |
|
Investments are made in early-stage technology companies by Inovia Capital.
|
Locked | Locked | Locked | |
|
Venture capital is invested in global technology companies by TCV.
|
Locked | Locked | Locked |
Investor details for Benchsci
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Benchsci
Investment portfolio details for Benchsci
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Benchsci
Detailed financials for Benchsci
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Benchsci Comparisons
Peer comparison for Benchsci
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Benchsci
Benchsci operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nona Biosciences, EPITOPIC, Deep Biologics, AB-Pred and NatIgGs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers antibody discovery, development, and engineering services for biotherapeutics.
|
|
| Locked | Locked | Locked |
Provider of cell therapy and antibody services
|
|
| Locked | Locked | Locked |
Provider of an AI-based antibody mining and screening platform for R&D work
|
|
| Locked | Locked | Locked |
Provides antibody prediction software for specialized applications.
|
|
| Locked | Locked | Locked |
Biotech startup discovers and improves natural antibodies for brain disease treatments using AI.
|
Detailed competitors of Benchsci
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Benchsci
Complete news archive for Benchsci
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Benchsci
Benchsci was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Benchsci is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Benchsci is a funded company, having raised a total of $157.73M across 8 funding rounds to date.
Founded in 2015 and based in Toronto, Canada, BenchSci operates in the biotechnology sector. An AI-based platform is provided to enable searches across millions of scientific papers for antibody usage evidence. Data is extracted and organized around specific antibodies to support reagent and antibody selection. Biomedical discoveries are facilitated through streamlined experiment design and data management processes.
Benchsci's top competitors include Deep Biologics, EPITOPIC and Nona Biosciences.
Benchsci offers ASCEND.
Benchsci has 12 investors. Key investors include Northleaf, Generation Investment Management, Inovia Capital, TCV, and F-Prime Capital.